AGT and cardiac hypertrophy: Interestingly, if AngII caused similar levels of cardiac hypertrophy in 13-month-old mice, in older animals, Ovx stopped cardiac hypertrophy related to aging during the second year of life but kept the heart’s capacity to respond to AngII.